1. HBW Insight
  2. >>Geography
  3. >>Europe

AESGP Conference Round-Up: Digital Disruption, Med Device Worries And The Benefits Of Switching

 
• By David Ridley

Speakers from the EMA and European Commission, as well as Pfizer and HRA Pharma, debated at the AESGP's Regulatory Conference the ongoing digital transformation of the European consumer healthcare market, the latest developments in the implementation of the new medical devices regulations, and the best ways to encourage Rx-to-OTC switching across the EU.

AESGP
AESGP's panel of industry experts discuss the 'digital transformation of regulatory science and healthcare'

This year’s Association of the European Self-Medication Industry, AESGP, Regulatory Conference was opened by recently-appointed director general Jurate Svarcaite, followed by deputy director general Maud Perrudin, who pointed out that it was a “time of uncertainty” for the European consumer healthcare industry.

Noting the significance of the conference’s location, in the Dutch capital Amsterdam, where the European Medicines Agency had moved to in the last few weeks as a consequence of the UK’s decision to exit the EU, she urged industry to nevertheless “try to embrace the changes

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

More from Geography

Melatonin And Buccal Acyclovir On German Switch Committee Agenda

 
• By David Ridley

An application for melatonin as an OTC medicine is on the agenda for the next German switch committee meeting, despite the hormone being widely available in food supplements. Acyclovir as a buccal tablet and second-generation antihistamine rupatadine are also up for discussion.

Over The Counter: Brands, Brexit And New Self-Care Business Models, With PAGB’s Michelle Riddalls

 
• By David Ridley

HBW Insight catches up with UK OTC industry association CEO Michelle Riddalls to talk about digital self-care and the unrealized promise of Brexit - part 2.

Plenty For Industry To Do As EU Wastewater Directive Faces Legal Challenges

 
• By David Ridley

Engaging with EU member state legislators, stressing the impact of national EPR systems on the accessibility, availability, and affordability of medicines, reformulating products to reduce their financial contribution, and lobbying for expanding the scope of EPR schemes to include other polluting industries are all ways that the European consumer health industry can try and influence the way that the revised Urban Wastewater Treatment Directive is transposed into national legislation, law firm Mason Hayes & Curran explains.